Intravesical therapy with pertussis toxin before radical cystectomy in patients with bladder cancer: A phase I study

Urology

Volumn 54, Issue 3, 1999, Pages 458-460

  Otto, Thomas ^a   Lümmen, Gerd ^b   Kälble, Tilmann ^b   Recker, Franz ^b   Krege, Susanne ^b   Bex, Axel ^b   Noll, Friedhelm ^b   Rübben, Herbert ^b  

^a UNIVERSITY OF ESSEN MEDICAL SCHOOL   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PERTUSSIS TOXIN;

ADULT; ARTICLE; BLADDER CANCER; BLADDER SURGERY; CELL MOTILITY; CLINICAL ARTICLE; CLINICAL TRIAL; CYSTECTOMY; DRUG EFFECT; DRUG SAFETY; DRUG TOLERABILITY; HUMAN; INTRAVESICAL DRUG ADMINISTRATION; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL;

ADMINISTRATION, INTRAVESICAL; AGED; CARCINOMA, TRANSITIONAL CELL; CYSTECTOMY; FEMALE; HUMANS; MALE; MIDDLE AGED; PERTUSSIS TOXIN; PREOPERATIVE CARE; PROSPECTIVE STUDIES; URINARY BLADDER NEOPLASMS; VIRULENCE FACTORS, BORDETELLA;

EID: 0032865944     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(99)00154-5     Document Type: Article

References (16)

1. De Mulder PH, Debruyne FM, Keizer HJ, et al: Randomized phase II study of methotrexate (M), cisplatin (C), and vinblastine (V) in patients with advanced transitional carcinoma of the bladder. Eur Urol 18(suppl 1): 5, 1990.
2. Hillcoat BL, Raghavan D, Matthews J, et al: A randomized trial of cisplatin versus cisplatin plus methotrexate in advanced cancer of urothelial tract. J Clin Oncol 7: 706-709, 1989.
3. Otto T, Bex A, Krege S, et al: Paclitaxel based second line therapy for patients with advanced chemotherapy resistant bladder carcinoma (M1). Cancer 80: 465-470, 1997.
4. Khandekar JD, Elson PJ, De Wys WD, et al: Comparative activity and toxicity of cis-diamminedichloroplatinum (DDP) and a combination of doxorubicin, cyclophosphamide, and DDP in disseminated transitional cell carcinoma of the urinary tract. J Clin Oncol 3: 539-544, 1985.
5. Loehrer PJ, Elison P, Kuebler JP, et al: Advanced bladder cancer: a prospective intergroup trial comparing single agent cisplatin (CDDP) vs M-VAC combination therapy. Proc Am Soc Clin Oncol 9: A511, 1990.
6. Logothetis CJ, Dexeus FH, Fin L, et al: Preliminary results of a prospective randomized trial comparing CISCA to MVAC chemotherapy for patients with advanced transitional cell carcinomas of the urothelium. Proc Am Soc Clin Oncol 7: 134, 1989.
7. Sternberg CN, Yagoda A, Scher HI, et al: M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced transitional cell carcinoma of the urothelium. J Urol 139: 461-469, 1988.
8. Hall RR: Neoadjuvant CMV chemotherapy and cystectomy or radiotherapy in muscle invasive bladder cancer. First analysis of MRC/EORTC intercontinental trial. Proc Am Soc Clin Oncol 15(suppl): 612, 1996.
9. Freiha IR, and Torti F: Locally advanced bladder cancer treated with radical cystectomy and adjuvant chemotherapy. Results of a randomized prospective study. J Urol 151: 53A, 1994.
10. Skinner DG, Daniels JR, Russell CA, et al: The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer: a prospective comparative trial. J Urol 145: 459-467, 1991.
11. Otto T, Birchmeier W, Schmidt U, et al: Inverse relation of E-cadherin and autocrine motility factor receptor expression as a prognostic factor in patients with bladder carcinoma. Cancer Res 54: 3120-3123, 1994.
12. Otto T, Bex A, Schmidt U, et al: Improved prognosis assessment for patients with bladder carcinoma. Am J Pathol 150: 1919-1923, 1997.
13. Lümmen G, Virchow S, Rümenapp U, et al: Identification of G protein-coupled receptors potently stimulating migration in human transitional-cell carcinoma cells. Naunyn Schmiedebergs Arch Pharmacol 356: 769-776, 1997.
14. Otto T, Raz A, Goepel M, et al: Inhibition of tumor cell motility with pertussis toxine prevents tumor progression in bladder cancer disease. J Urol 157: 51, 1997.
15. Liotta LA, Stracke ML, Aznavoorian SA, et al: Tumor cell motility. Semin Cancer Biol 2: 111-114, 1991.
16. Stossel TP: On the crawling of animal cells. Science 260: 1086-1094, 1993.